Entry |
|
Symbol |
CASP3
|
Name |
|
KO |
|
Organism |
shr Sarcophilus harrisii (Tasmanian devil)
|
Pathway |
shr04650 | Natural killer cell mediated cytotoxicity |
shr04932 | Non-alcoholic fatty liver disease |
shr04933 | AGE-RAGE signaling pathway in diabetic complications |
shr05022 | Pathways of neurodegeneration - multiple diseases |
shr05163 | Human cytomegalovirus infection |
shr05167 | Kaposi sarcoma-associated herpesvirus infection |
shr05168 | Herpes simplex virus 1 infection |
shr05170 | Human immunodeficiency virus 1 infection |
|
Brite |
KEGG Orthology (KO) [BR:shr00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
100922500 (CASP3)
04668 TNF signaling pathway
100922500 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
100922500 (CASP3)
09143 Cell growth and death
04210 Apoptosis
100922500 (CASP3)
04215 Apoptosis - multiple species
100922500 (CASP3)
04115 p53 signaling pathway
100922500 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
100922500 (CASP3)
04650 Natural killer cell mediated cytotoxicity
100922500 (CASP3)
04657 IL-17 signaling pathway
100922500 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
100922500 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
100922500 (CASP3)
05206 MicroRNAs in cancer
100922500 (CASP3)
05205 Proteoglycans in cancer
100922500 (CASP3)
05203 Viral carcinogenesis
100922500 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
100922500 (CASP3)
05222 Small cell lung cancer
100922500 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
100922500 (CASP3)
05161 Hepatitis B
100922500 (CASP3)
05160 Hepatitis C
100922500 (CASP3)
05164 Influenza A
100922500 (CASP3)
05162 Measles
100922500 (CASP3)
05168 Herpes simplex virus 1 infection
100922500 (CASP3)
05163 Human cytomegalovirus infection
100922500 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
100922500 (CASP3)
05169 Epstein-Barr virus infection
100922500 (CASP3)
05165 Human papillomavirus infection
100922500 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
100922500 (CASP3)
05133 Pertussis
100922500 (CASP3)
05134 Legionellosis
100922500 (CASP3)
05152 Tuberculosis
100922500 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
100922500 (CASP3)
05145 Toxoplasmosis
100922500 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
100922500 (CASP3)
05012 Parkinson disease
100922500 (CASP3)
05014 Amyotrophic lateral sclerosis
100922500 (CASP3)
05016 Huntington disease
100922500 (CASP3)
05020 Prion disease
100922500 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
100922500 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
100922500 (CASP3)
05416 Viral myocarditis
100922500 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
100922500 (CASP3)
04932 Non-alcoholic fatty liver disease
100922500 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
100922500 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
100922500 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:shr01002]
100922500 (CASP3)
Enzymes [BR:shr01000]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
100922500 (CASP3)
Peptidases and inhibitors [BR:shr01002]
Cysteine peptidases
Family C14: caspase family
100922500 (CASP3)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
6:complement(117732456..117751495)
|
AA seq |
275 aa
MENTEITIDSKSSKSSGLKIFHGSKSVESGLSSDSYKMDYPEMGLCVIINNKNFHPNTGM
SFRSGTDVDAAHLRDTFKSLKYEVRNKNDLTCKEIIELLYNVSKEDHSQRSSFVCVILSH
GEEGIIFGTDGSVELKRLTYFFKGDKCKSLTGKPKLFIIQACRGTELDCGIETDSATDDV
TCQKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAVLKQYAYKLEIMQILTRVNRK
VATEFESYSLDATFHAKKQVPCIMSMLTKELYFFP |
NT seq |
828 nt +upstreamnt +downstreamnt
atggaaaatactgaaattacaatagattcaaagtcctccaaaagttcaggattaaagatc
ttccatggtagcaagtctgtggaatctggactgtcatcagacagctataaaatggattat
ccagaaatggggttatgtgtaatcataaataataaaaattttcacccaaacactggcatg
tcttttcggtctgggactgatgtagatgcagcacatctcagggatacattcaaaagcttg
aaatatgaagtcagaaataaaaatgatttgacatgtaaagaaataattgaattactttac
aatgtttctaaagaagatcacagccaaaggagcagttttgtttgtgtgattctaagtcat
ggtgaagaaggaatcatctttgggacagatggatctgttgaactgaaaagattaacatat
ttctttaaaggggataagtgtaaaagtcttacaggaaaaccaaagctttttatcattcag
gcatgtagaggcacagagttggattgtggtattgagacagatagtgccactgatgatgta
acatgccagaaaatacctgttgaggcagacttcttatatgcttattctacagccccaggt
tactattcttggagaaattcaaaggatggttcatggtttatccagtcactttgtgcagtg
ctgaaacagtatgcttacaagcttgaaatcatgcaaatccttaccagagtcaatcggaag
gttgccacagagtttgaatcttactccttagatgctaccttccatgcaaagaaacaggtg
ccatgtatcatgtccatgcttactaaggaactatattttttcccctaa |